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Background: The ability to produce the same recombinant protein in both prokaryotic and eukaryotic cells offers
many experimental opportunities. However, the cloning of the same gene into multiple plasmids is required, which
is time consuming, laborious and still may not produce soluble, stable protein in sufficient quantities. We have
developed a set of expression vectors that allows for ligation-independent cloning and rapid functional screening
for protein expression in both E. coli and S. cerevisiae.
Results: A set of expression vectors was made that can express the same open reading frame in E. coli (via the T7
phage promoter) and in S. cerevisiae (via the CUP1 or MET25 promoter). These plasmids also contain the essential
elements for replication and selection in both cell types and have several advantages: they allow for cloning of
genes by homologous recombination in yeast, protein expression can be determined before plasmid isolation and
sequencing, and a GST-fusion tag is added to aid in soluble expression and purification. We have also included a
TEV recognition site that allows for the specific cleavage of the fusion proteins to yield native proteins.
Conclusions: The dual promoter vectors can be used for rapid cloning, expression, and purification of target
proteins from both prokaryotic and eukaryotic systems with the ability to study post-translation modifications.Background
Often times, the gathering of reagents to preform a spe-
cific experiment can be more difficult than the execu-
tion of the experiment itself. This can especially true of
experiments that examine the molecular interactions be-
tween proteins, which require the expression and purifi-
cation of recombinant protein(s) from both eukaryotic
and prokaryotic systems. Both systems have unique
advantages for recombinant protein expression: prokary-
otic E. coli allow for large quantities of recombinant pro-
tein to be easily and rapidly expressed and S. cerevisiae
allow for eukaryotic proteins to be expressed with native
binding partners and for in vivo function assessment.
However, for the same protein to be produced in both
systems multiple expression plasmids are typically used
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reproduction in any medium, provided the orselection, mRNA transcription, and protein translation for
the two systems are different. The construction and verifi-
cation of these multiple plasmids is time consuming, la-
borious, and error prone. Additionally, plasmids must be
shuttled between different host strains for the cloning and
expression steps.
We set out to overcome these experimental hurdles by
combining into a single vector all of the essential elements
for recombinant protein expression in both bacteria and
yeast in a one-step, ligation-independent process. The
benefits of expression plasmids that work in both bacterial
and other eukaryotic cells have been noted previously
[1,2]. Additionally, these vector systems have also touted
the benefit of one-step cloning. However, the use of exist-
ing vectors has been limited to recombinant protein
expression in either mammalian or insect cells and leaves
a gap in the available expression tools in yeast. The vec-
tors described here have several advantages; (1) genes can
be cloned into the vectors in a ligation-independenttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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screen for protein expression and functionality can be
used to identify positive clones in yeast before isolation of
the plasmid DNA, (3) a protein can be expressed in both
bacterial and yeast from the same vector, (4) a GST-fusion
tag, which can be removed by the treatment with TEV
protease, is provided to enhance protein solublility and
purification, and (5) the entire protocol is very time effi-
cient taking less than a week (5 days, 6 hours of hands-on
time) to complete. To our knowledge, these are the first
examples of dual promoter vectors that allow for one-step
cloning for both bacterial and yeast expression.
The pDEP vectors contain all of the fundamental fea-
tures spanning plasmid replication to protein transla-
tion within both bacteria and yeast. The plasmids were
named pC-DEP and pM-DEP for Dual Expression Pro-
moter (pDEP) and are otherwise identical except the
open-reading frame of interest are under the control of
either yeast CUP1 (pC-DEP) or MET25 (pM-DEP) pro-
moters, respectively. The CUP1 promoter drives inter-
mediate levels of protein expression upon the addition
cuprous ions to growth media [3]. The MET25 promoter
drives modest levels of expression in complete media,
but is derepressed in the absence of methionine to drive
high levels of protein expression [4]. For protein expres-
sion in bacteria, a T7 bacteriophage promoter and ribo-
some-binding site is located between the yeast promoter
and the translation start codon. The vectors contain the
URA3 gene for growth selection in ura3 mutant yeast
grown on uracil deficient media. Also, the ampicillin re-
sistance gene, β-lactamase (bla), is included for selection
of bacteria grown on ampicillin-containing media. The
yeast CEN/ARS4 origin of replication and the bacterial
pMB1 ori affords replication of the plasmid in the respect-
ive systems. An additional feature is the inclusion of a
GST-fusion tag at either the N-terminus or C-terminus
of the open-reading frame of interest to enhance protein
solubility and protein purification. Combination of these
features into a single plasmid streamlines the process of
recombinant protein expression.
Despite of what appears to be a simple modular com-
bination of the above-mentioned features, several unex-
pected difficulties had to be overcome in our studies to
isolate a fully functional set of plasmids and procedures
to enhance their performance. We demonstrated the
utility of our system to rapidly clone, screen, express,
and purify recombinant proteins by cloning 6 different
ubiquitin-like (Ubl’s) proteins into the vectors.
Results
Design of pDEP vectors
The pDEP vectors were designed to include all of the es-
sential elements for efficient replication, selection, mRNA
transcription, and protein translation within bothbacteria and yeast (Figure 1A and B). The yeast origin
of replication chosen was the CEN6 and the ARS asso-
ciated with Histone 4 (CEN6/ARS4). The URA3 gene,
which allows for growth on media lacking uracil, was
included as an autotrophic selection marker in yeast.
Protein expression in yeast is under the control of the
copper inducible promoter from the CUP1 gene or the
methionine-regulated MET25 promoter. The CYC1 ter-
minator was selected as the yeast translation terminator.
The bacterial origin of replication, pMB1, and ampicillin
resistance gene, β-lactamase (bla), were also selected for
inclusion. The T7lac promoter was chosen to drive pro-
tein expression in bacteria and was placed directly after
the yeast promoter and ~25 bp before a ribosome
binding site (RBS). The T7lac promoter is a combination
of the T7 bacteria phage promoter placed upstream of the
lac operator (lacO) sequence, a binding site for the lac re-
pressor. Protein expression is induced upon expression of
T7 polymerase in DE3 lysogenized cells using IPTG and
the lacO sequence functions to repress basal transcription
of the gene of interest from the T7 polymerase. However,
the final vectors did not contain the lacO sequence, see
Discussion section for details.
Additionally, the coding sequence of Glutathione S-
transferase (GST) protein was incorporated to allow for
an in-frame fusion-tag. The pDEPN and pDEPC vectors
allow for the gene of interest to be inserted at the N-
terminus or C-terminus of the encoded GST fusion tag,
respectively.
A tobacco etching virus (TEV) protease cleavage site
is integrated between the GST-fusion tag and the coding
sequence of the gene of interest in the pDEPC vectors.
When recombinant protein containing this site is treated
with TEV protease, it is specifically cleaved at the TEV
site to produce native protein. A multiple cloning site
(MCS) was also included between the TEV cleavage site
and the CYC1 terminator to allow for linearization of
the plasmid for the insertion of a gene of interest.
Construction of pDEP vectors
The pDEP vectors were assembled by the homologous
recombination of multiple PCR amplicons to a linearized
target plasmid (as described in materials and methods).
The target plasmid, pRS316, contained the yeast origin
of replication (CEN/ARS4) and nutritional selection mar-
ker (URA3), and the pMB1 bacterial origin of replication
and the ampicillin resistance gene, β-lactamase (bla).
The PCR primers were designed to amplify the CUP1
promoter, the T7lac promoter and ribosome binding se-
quence, the coding sequence for the GST-TEV fusion
tag, and the CYC1 terminator. The T7lac promoter was
designed to have binding sites for both T7 RNA poly-
merase and LacI, which induces protein expression and
prevents basal gene transcription in repressed bacteria,
Figure 1 Schematic representation of pDEPC vectors. (A) Schematic of pC-DEPC and pM-DEPC vectors with the following features labeled:
URA3 ORF in blue, f1 ori in white, CUP1 yeast promoters in green, MET25 yeast promoters in orange, glutathione S-transferase gene (GST) in
yellow, the CYC1 yeast transcription terminator in red, the pBM1 origin of replication in white, and the bla gene conferring ampicillin resistance in
grey. Unique restriction sites are labeled. (B) Nucleotide sequence of the translation initiation region and corresponding protein translation are
shown. This region positions the prokaryotic T7 promoter and ribosomal binding site (RBS) after the eukaryotic CUP1 or MET25 promoters. A TEV
protease cleavage site is located between the GST-tag and the insertion site for the ORF of interest. (C) Nucleotide sequence of the multiple
cloning site (MCS).
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additional flanking sequences of ~50 bp, Additional file 1:
Figure S1. The flanking sequences targeted the resulting
linear amplicons for recombination with the intended
neighboring sequences and the target plasmid via an
“ends-out” double strand break repair mechanism. This
was achieved by co-transformation of the PCR amplicons
and linearized target plasmid into yeast. A fraction of
the linearized plasmid simultaneously acquired the
PCR amplicons and was recircularized. Recombinants
that contain the recircularized plasmid encoding the
URA3 gene were selected for on media lacking uracil.
Control transformations of linearized plasmid DNA
alone or PCR amplicons alone did not yield asignificant number of transformants (< 20) while the
‘complete’ transformation contained several hundred
transformants (data not shown).
Each individual yeast transformant represented a sin-
gle recombination event and contained a single plasmid.
A plasmid that correctly recombined would contain all
the necessary elements for replication, selection, mRNA
transcription, and protein translation in yeast. Hence,
the ability to produce recombinant GST protein was used
as a read out for these correct recombination events. This
was assessed by immunoblot analysis with α-GST anti-
bodies of individual yeast transformants. When transfor-
mants were grown in liquid culture containing 100 μM
CuCl2, expression of GST protein was induced from the
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transformants, only one was found to produce high levels
of GST protein. This plasmid was rescued from yeast and
transformed into E. coli. Upon sequencing, it was found
that this plasmid contained the T7 RNA polymerase-bind-
ing site but lacked the flanking sequence required for LacI
binding. This suggested that by using screening in yeast,
we were able to find a mutant variant capable of proper
yeast expression. Upon introduction of the plasmid into
BL21 (DE3) cells, the production of large amounts of
GST-fusion protein was assessed using SDS-PAGE and
staining with Coomassie Brilliant Blue. This initial plasmid
then served as the basis for all of the modified pDEP vec-
tors described below. For versatility, a multiple cloning
site replaced the 3’ region of this initial plasmid to pro-
duce pC-DEPC.
The pM-DEPC plasmid was constructed to have the
MET25 promoter in place of the CUP1 promoter. TheFigure 2 Use of pC-DEPN plasmid for making untagged or N-terminal
following features labeled: URA3 ORF in blue, f1 ori in white, CUP1 yeast pr
CYC1 yeast transcription terminator in red, the pBM1 origin of replication in
Unique restriction sites are labeled. Nucleotide sequence of the translation
the pC-DEPN plasmid. The unique SacII site allows for genes of interest to b
of the function of pC-DEPN plasmid. Left panel: Western blot analysis using
the Hua1 gene that were recombined into the pC-DEPN plasmid. Right pan
fusion proteins as in left panel purified from BL21 (DE3) cells using GSH-agMET25 promoter had the advantage that it is tightly
regulated by the presence of methionine in growth
media: strong protein expression is seen in the absences
of methionine and is not detectable in the presence of
10 μg/ml methionine. A PCR amplicon was engineered
to include the MET25 promoter and ~50 bp of flanking
sequence on each end. This was integrated in place of
the CUP1 promoter of pC-DEPC to produce pM-DEPC,
Figure 1.
In a similar manner, the pC-DEPC plasmid was modi-
fied to produce pC-DEPN plasmid. The pC-DEPN plas-
mid allows for the expression of either native protein or
with a C-terminal GST-fusion tag, Figure 2. pC-DEPC
differs from pC-DEPN by the inclusion of SacII endo-
nuclease site after the start codon of the GST coding
sequences. (Note that the TEV cleavage site and MCS of
the original pC-DEPC plasmid remain intact). Once the
pC-DEPN is linearized at the SacII site, a gene of inte-GST-fusion proteins. Schematic of pC-DEPN plasmid with the
omoters in green, glutathione S-transferase gene (GST) in yellow, the
white, and the bla gene conferring ampicillin resistance in grey.
initiation region and corresponding protein translation sequence of
e recombined upstream of the GST coding sequence. Demonstration
α-GST antibodies of yeast cultures expression the indicated residues of
el: Coomassie Brilliant Blue stained SDS-PAGE gel of the same GST-
arose.
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quence. If the coding sequence of the gene of interest
includes a stop codon, the recombinant protein pro-
duced within the native, untagged form. However, if it
does not include a stop codon, the recombinant protein
produced will include a C-terminal GST-fusion tag.
Using the pDEP Vectors
The workflow and time required for cloning a gene of
interest into the pDEP vectors is outlined in Figure 3A.
The first step involves preparing the target by diges-
tion with endonucleases specific for the sites within the
MCS of pC-DEPC or pM-DEPC or the SacII site within
pC-DEPN. Simultaneously, a PCR amplicon containing
the gene of interest and ~50 bp flanking sequences with
homology to the target plasmid is made. The resulting
DNA fragments are then prepared and co-transformed
into yeast. The transformation mixture is plated onFigure 3 Workflow of ligation-independent cloning into the pDEP vec
with each step of cloning a gene of interest into the pDEP vectors. From b
time. (B) Agarose separating gel visualized with ethidium bromide. Lane 1:
of the HECT-domain of Rsp5 (Rsp5HECT, residues 446–809). (C) DNA fragme
media. Top plate (−), negative control containing only digested plasmid, an
digested vector. (D) Western blot analysis for positive recombination event
not containing an ORF, and lane 2, expression of GST-Rsp5HECT from recom
plasmid insertion site and the PCR product designed to integrate into the
ends can be generated as part of the PCR primers and will place the open reselective media lacking uracil and incubated for two
days. On the third day, the individual yeast transfor-
mants are inoculated into selective media containing the
proper protein induction condition: either 100 μM
CuCl2 in the case of the CUP1 promoter or absence of
methionine in the case for the MET25 promoter. The
next day, day 5, individual transformants are then
assayed for the production of the GST-fusion protein by
immunoblot with α -GST antibodies. This screens for
correct recombination events of the PCR amplicon with
the target plasmid. The recircularized plasmid is then
rescued from yeast transformants that show robust pro-
tein expression in the yeast cultures on the same day.
Immediately this plasmid DNA can be transformed into
a bacterial expression strain and the bacterial culture
grown overnight. On day six, the bacterial culture in
induced with the addition of IPTG to the culture media.
Again, the culture can be assayed for recombinanttors. (A) Experimental steps, timeline, and hands-on time associated
eginning to end, cloning take less than 5 days and ~6 hr of hands-on
digested vector pC-DEP, lane 2: DNA size marker, lane 3, PCR product
nts from Figure 3B was transformed into yeast and plated on selective
d Bottom plate (+), successful recombination of PCR product and
s using α-GST antibodies. Lane 1, GST protein expression from pC-DEPC
bination plasmid pC-DEPC- Rsp5HECT. (E) Schematic view of the
pDEP plasmids via homologous recombination in yeast. The flanking
ading frame of interest in frame with the 5’ GST open reading frame.
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corresponding to the predicted molecular weight of the
GST-fusion protein by SDS-PAGE gel stained with Coo-
massie Brilliant Blue or by probing with α-GST anti-
bodies. Overall, the procedure takes a total of five days
(6 hours hands-on time) to produce a plasmid that has a
confirmed protein expression in both yeast and bacteria.
Figures 3B-3D illustrate different steps in the workflow
of cloning a gene of interest, in this case the HECT-do-
main of the ubiquitin ligase Rsp5, into the pC-DEPC
plasmid. Using the sequences shown in Figure 3E, PCR
oligos were designed to amplify regions of the Rsp5 open
reading frame and included ~50pb of homology to the
pC-DEPC vector. The resulting PCR product is shown
in lane three of Figure 3B. The pC-DEPC plasmid was
linearized at restriction enzyme sites within the MCS,
lane 1 in Figure 3B. The DNA fragments were then co-
transformed into yeast and plated on selective media,
Figure 3C, lower panel. We found that ample yeast trans-
formants were typically obtained using ~1 μg each of
linearized plasmid and PCR product. Figure 3C, upper
panel displays the typical results from the control trans-
formation of linearized plasmid alone. Comparison of the
upper and lower panels of Figure 3C clearly illustrates the
efficiency of recombination of the PCR amplicon with the
target plasmid.
In order to screen for correct recombination events that
produced a recircularized plasmid with the Rsp5 HECT-
domain inserted, individual yeast transformants were ana-
lyzed by immunoblot with α-GST antibodies after growth
in selective media containing CuCl2. These conditions
induced expression of the GST-Rsp5HECT fusion protein,Figure 4 Expression of protein in both bacteria and yeast from the p
CUP1 and MET25 promoters in yeast by Western blot analysis of yeast lysat
panel, protein expression from pC-DEPC-MVB12 plasmid under the control
and right panel is same protein expressed under control of the MET25 prom
methionine. (B) Comparison of protein expression levels from the indicated
are labeled U for uninduced and I for induced with 0.2 mM IPTG for 2 hrs.
Brilliant Blue. White circles in induced lanes indicate the GST-MVB12 fusionwhich was under control of the CUP1 promoter. An ex-
ample of this assay is shown in Figure 3D. Lane one is
recombinant GST protein (~26 kDa) produced from the
pC-DEPC vector without a gene insert and serves as a
control. The dominant band in lane two of Figure 3D is at
~75 kDa, the predicted molecular weight for the GST-
Rsp5HECT fusion protein produced by the pC-DEP-
Rsp5HECT plasmid. In general, 5–10 yeast colonies were
screened in this way for the presence of the GST-fusion
protein. Typically, less than 10% failed to combine the
gene of interest into the target plasmid (data not shown).
These colonies either did not express any proteins
detected with the α-GST antibodies or produced a band at
~26 kDa, representing GST alone. One major advantage
of this workflow is that plasmids within individual trans-
formants can be screened on the basis of their expression,
ensuring that a plasmid can be identified that encodes a
full-length protein and can be produced at desired levels.
Protein expression and optimization
The pDEP set of vectors allows for control of protein pro-
duction in yeast to be under the control of the CUP1 pro-
moter (pC-DEPC) or the MET25 promoter (pM-DEPC).
Comparison of protein expression from these two promo-
ters is illustrated in Figure 4A. In this instance, the gene
encoding the Class E Vps protein MVB12 was cloned
into both the pC-DEPC and pM-DEPC vectors. For
the pC-DEPC-Mvb12 plasmid, the addition of CuCl2
(25–100 μM) to the culture media rapidly induces strong
production of the GST-Mvb12 fusion protein at 38 kDa,
right lane mark I in the left panel of Figure 4A. In
addition, protein expression can be suppressed below theDEPC plasmids. (A) Comparison protein expression levels from the
es using α-GST antibodies of GST-MVB12 fusion protein (38KDa). Left
of the CUP1 promoter was induced by the addition of copper chloride;
oter using pM-DEPC-MVB12 plasmid, induced by the absence of
E. coli strains transformed with the pC-DEPC-MVB12 plasmid. Lanes
Bacteria lysates were separated by SDS-PAGE gel stained by Coomassie
protein (38 kDa).
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the copper chelating agent BCS to the culture media (left
lane marked U, in left panel of Figure 4A). Low levels of
expression is seen from the pC-DEPC plasmid in media
without either CuCl2 or BCS added, presumably due to re-
sidual amounts of cupric ions in the water used (data not
show). The MET25 promoter also yields robust and regu-
lated protein expression. Protein expression from the
MET25 promoter is induced by growing cells in the ab-
sence of methionine and suppressed by the addition of
10 μg/ml methionine to the growth media (Figure 4A, left
panel labeled I and U, respectively). In general the CUP1
promoter produced tighter control over protein expres-
sion while the MET25 promoter provided slightly stronger
protein expression.
Bacterial protein expression from the pDEP plasmids
is under control of the T7 RNA polymerase in DE3 lyso-
genized cells (λDE3). Robust protein expression was
detected when 1 mM IPTG was added to culture media.
However, the method used to transform λDE3 cells and,
to a lesser extent, the specific strain of λDE3 cells
was critical for expression in E. coli. We found that the
pDEP plasmids could only be reliably transformed into
λDE3 cells if the transformants were grown in media
(or plated on media) containing a lower amount of ampli-
cilin (25 μg/ml). Once transformants had grown over-
night, the E. coli culture could be grown in media with up
to 100 μg/ml ampicillin and robustly produced the desired
recombinant protein (Additional file 2: Figure S2).
Several types of λDE3 bacterial strains were screened
for the highest and most consistent level of recombinant
protein production from the pC-DEPC-Mvb12 plasmid.
In general, bacterial strains derived from the λDE3 lyso-
genized K-12 E.coli strains (HMS147 and NovaBlue,Figure 5 Expression of multiple Ubl proteins from both bacteria and
antibodies of yeast lysates expressing the indicated GST-fusion proteins. Th
pC-DEPC vector and induced with copper chloride. (B) Coomassie Brilliant B
(BL21(DE3)) transformed with the identical plasmids in Figure 5A.marked by white dots in Figure 4B) produced little or no
detectable protein at the predicted molecular weight of
38 kDa. However, several λDE3 B strain derivatives in-
cluding BL21, BLR, and Turner cells all worked very
well, Figure 4B, marked by white dots. It was also found
that comparable levels of recombinant protein were pro-
duced in bacteria when the same construct, GST-Mvb12,
was contained in an E. coli expression plasmid pGEX-3X
(data not shown).
To demonstrate the utility of the pC-DEPC system, we
generated a number of GST-fusion constructs in parallel
(Figure 5). Several coding sequences for ubiquitin like
(Ubl) proteins of yeast were amplified and recombined
in yeast using linearized pC-DEPC. Recombinant plas-
mids were isolated from yeast and retransformed into
yeast and bacteria (BL21(DE3)). Production of GST-Ubl
proteins were induced with 100 μM CuCl2 in yeast and
visualized by immunoblotting with α-GST antibodies.
The GST-Ubl proteins produced in bacteria upon IPTG
induction were purified using GSH-agarose resin and
analyzed by SDS-PAGE and Coomassie Brilliant Blue
staining. All of these constructs were made in the same
time scale as the workflow described in Figure 3A,
showing that this system is robust for making several
functional constructs in parallel.
To test the functionality of the pC-DEPN plasmid,
which allows for C-terminal fusion of GST to proteins,
several portions of the Hua1 gene were incorporated,
Figure 2. After the pC-DEPN plasmid was linearized with
SacII endonuclease, it recombined PCR amplicons en-
coding the N-terminal 22, 44, or 69 residues of the yeast
Hua1 protein. Two yeast colonies from each transform-
ation were grown in CuCl2 overnight and analyzed for
expression of the Hua1-GST fusion proteins byyeast in the pC-DEPC vector. (A) Western blot analysis using α-GST
e designated ubiquitin-like domains (Ubls) were recombined into the
lue stained SDS-PAGE gel of GST-fusion proteins purified from bacteria
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from yeast and transformed into BL21 (DE3) cells. Re-
combinant proteins from bacterial cultures induced with
IPTG were affinity purified over GSH-agarose and
analyzed by SDS-PAGE and Coomassie Brilliant Blue
staining (Figure 2C).
Discussion
The pDEP vectors designed in this study allow for the
rapid cloning of genes for expression of recombinant
proteins in both prokaryotic and eukaryotic systems
from a single vector. Genes of interest are cloned into
the pDEP vectors in a ligation-independent manner by
exploiting the ability of yeast to perform homologous re-
combination rapidly and efficiently. A gene of interest is
targeted for integration into the pDEP vectors by the
addition of specific homologous sequences, which are
designed into the oligos for the gene of interest, by PCR
amplification. This cloning procedure has several unique
advantages over ligation-dependent subcloning methods.
Firstly, traditional subcloning is a several step process
requiring the gene of interest to be cloned from genomic
DNA, put into a shuttle vector and subsequently trans-
ferred to an expression plasmid. Most often restriction
enzymes are used and the efficiency of subcloning
decreases with the increased size of the insert. Each step
in this process has the potential for error and failure and
requires sequencing to confirm the construct. Further-
more, restriction endonucleases used for these proce-
dures may not be compatible with the gene of interest
and render it useless for recombinant protein expres-
sion. Additionally, several plasmids are currently needed
in order to express proteins in the two different systems,
compounding the time and difficulty of the subcloning
task. Finally, subcloning methods require the resulting
plasmid to be transferred into an expression strain,
which can lead to the discovery that the construct either
does not produce protein in sufficient quantities or that
it is not soluble. Many systems have been created (such
as Invitrogens Gateway and TOPO cloning systems) to
help overcome these hurdles, yet do not address all of
these difficulties.
The pDEP vectors offer a cohesive and simple way to
solve these problems. Cloning into the pDEP vectors is
a one-step, ligation-independent process, streamlining
the procedure greatly. A gene of interest can be direct-
ly amplified by PCR from genomic DNA using oligos
designed with flanking sequences homologous to all of
the pDEP vectors. This PCR amplicon can then be dir-
ectly recombined into the target plasmid by transform-
ation into yeast. This bypasses the problem of using
restriction enzymes with the gene of interest. Homolo-
gous recombination is also not hampered by a large
sized insert, as Gibson et. al. demonstrates the ability ofS. cerevisiae to combine 25 DNA fragments ranging
from 17 to 31kbp in size [5]. Similarly, homologous re-
combination provides the ability to produce chimeric
proteins constructed from multiple coding sequences.
Moreover, the host strain for the recombination, yeast,
is also able to serve as an expression strain when grown
in the proper conditions to induce protein expression.
This directly provides a critical readout of the quality
and quantity of recombinant protein produced from the
plasmid before it is isolated and sequenced. This is not
possible with the commercially available systems. Lastly,
the pDEP plasmid can then be transferred into a bacter-
ial expression strain for recombinant protein expression
in a prokaryotic system. This eliminates the need for
additional subcloning and isolation steps and also the
need for the sequencing of multiple constructs. From
start to finish, the method takes roughly 5 days, includ-
ing 6 hours of hands-on time, which is a significant
timesaving over traditional subcloning.
It should be noted that there are commercially available
technologies that would be compatible with the pDEP
vectors. Although not tried here, it should be possible to
obtain proper pDEP clones using ligation-independent
cloning in E.coli using the In-Fusion enzyme (Clontech)
and similar PCR products used for yeast recombination.
However, this method would require the resulting plas-
mid be transferred to an expression strain, either E. coli
or S. cerevisiae.
Having a bacterial/yeast expression system for recom-
binant protein expression offers other advantages be-
yond rapid vector construction and functional screening.
Isolating the same protein from both yeast and bacteria
allows for a more stringent evaluation of eukaryotic spe-
cific post-translational modifications by methods such as
mass spectroscopy, SDS-PAGE mobility, and others. The
same polypeptide could be expressed in the two systems
and then the properties directly compared. For example,
Atg8p is an integral component of the yeast autophagy
system and is covalently attached to the membrane
phospholipid phosphatidylethanolamine (PE) post-trans-
lationally. When produced in bacteria, the GST-ATG8
fusion protein appears at the predicted molecular weight
of ~40 kDa, Figure 5B, left most lane. However, when
produced in a eukaryotic system that includes the native
conjugation machinery, additional bands are detected in
for the GST-ATG8 fusion protein, Figure 5A, left most
lane. A similar trend is seen for Dsk2p, a known target
for ubiquitination, fifth lane in Figures 5A and 5B. The
original pC-DEPC vector would not be ideal for investi-
gating all post-translational modifications in this way
since the N-terminus is critical for directing proteins
into specific cellular locations and is blocked by the
GST-fusion tag. However, the pC-DEPN plasmid allows
for insertion of fragments upstream of the GST coding
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untagged protein or C-terminal GST-fusion tags. Add-
itionally, pC-DEPN plasmid would also enable recombin-
ation strategies where the entire GST ORF could be
replaced with other protein fusion tags. Furthermore,
the pDEP vectors could streamline surface mapping stud-
ies designed to pin-point domains that mediate protein:
protein interaction. Using both bacterial and yeast ex-
pression systems could help differentiate between direct
and indirect interactions.
During the construction of the initial pDEP vector,
pC-DEPC, very few of the recombinants screened posi-
tive (1 in 50) for the production of GST protein in yeast.
This was quite unexpected because there were a consid-
erable number of transformants. However, sequencing of
this plasmid showed that a coincidental recombination
event had excised the lac operator (lacO) site of the
T7lac promoter. The lac repressor-binding site had been
positioned between the T7 promoter and the RBS and
was initially included to allow for tighter control of pro-
tein production in DE3 lysogenized E. coli. When we
repaired this error by site directed mutagenesis, the plas-
mid no longer produced GST to any detectable level in
yeast (data not shown). It is not clear why this small,
5 bp region between the CUP1 promoter’s transcrip-
tional start site and the start of the open reading frame
would be detrimental for expression in yeast. Our ability
to screen through several yeast colonies at the initial
stages of our study was critical to our ability to identify
the rare plasmid variants that ultimately worked. This
does explain why most of the initial yeast transformants
did not express protein and underscores the advantage
the pDEP system had in screening for plasmid variants
with desired expression characteristics.
Another unexpected result in this study was the diffi-
culty of reliably transforming pDEP plasmids into BL21
(DE3) cells for bacterial expression. Transforming pC-
DEPC plasmid, or the parent yeast expression plasmid
pRS316, fails to yield ampicillin-resistant cultures using
standard transformation conditions (Additional file 2:
Figure S2). Some benefit was observed upon adding 1%
glucose to cells during their initial growth in ampicillin
media (Additional file 2: Figure S2B). This was encour-
aging since it is known that glucose can repress basal
levels of T7 RNA polymerase, which might create growth
limiting products (RNA or protein) from pC-DEPC or
pRS316 plasmids, which themselves are high copy plas-
mids [6]. However, high levels of GST expression are not
toxic for bacteria. We also observed transformation pro-
blems with yeast expression plasmids that contained no
ORF downstream of the T7 promoter, suggesting that it is
not production of the GST fusion proteins per se that
were the source of the transformation problem. Rather it
may be another RNA derived from the plasmid. In side byside comparisons, we found the transformation problem
to be even worse in BL21 star (DE3) cells, which contain
the rne131 mutation that compromises the major enzyme
responsible for mRNA degradation [7,8]. Efforts to limit
T7 RNA polymerase activity by using BL21 (DE3) strains
with pLysS (which encodes T7 lysosome and inhibits tT7
RNA polymerase thus lowering its basal activity) did not
correct this defect. We also made a derivative of pC-DEP
containing the ROP gene, which is known to diminish the
copy number of plasmids that have the ColE1-related ori-
gin of replication (Additional file 2: Figure S2C). However,
while this did reduce plasmid copy number as assessed by
yield from plasmid preparation procedures, it did not re-
store transformation into BL21 under standard conditions
(Additional file 2: Figure S2A and S2B). The easiest and
most reliable remedy was simply to grow the initial cul-
tures of BL21 (DE3) cells in media (LB) containing 25 μg/
ml ampicillin after transformation rather than the 50–
100 μg typically recommended for high copy plasmids
(Additional file 2: Figure S2A). This level of ampicillin is
high enough to select for the plasmid and consistently
gave BL21 (DE3) transformants with all of our pDEP
plasmids.Conclusion
In this study, a set of plasmids was developed for the ex-
pression of proteins in both prokaryotic and eukaryotic
systems and named pDEP for Dual Expression Promoter.
Genes of interest are cloned into the vector in a ligation-
independent manner, greatly simplifying and streamlining
this procedure. The cloning procedure also allows for pro-
tein expression, solubility, and functionality to be screened
before the plasmids are isolated and sequenced. Further-
more, the pDEP vectors were optimized to overcome sev-
eral unforeseen experimental difficulties. These vectors
advance the available tools to researchers working with
both E. coli and S. cerevisiae.Methods
Bacterial strains, yeast strains, and growth conditions
Restriction enzymes were purchased from New England
Biolabs. PCR amplification was performed using Biolase
DNA polymerase (Bioline). The yeast strain BY4742
(MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) was transformed
by LiTE-Sorb method [9]. After transformation, yeast
were plated on SC-Ura-Met (Sunrise Scientific) agar
plates and incubated for 2 days at 30°C. Yeast were
grown in liquid cultures of SC-Ura-Met at 30°C with
shaking. Stock solutions of methionine and copper
chloride were prepared at 1000x concentrations and
added to liquid yeast cultures. The copper chelating
agent BCS (bathocuproine sulfonic acid) was purchase
from Sigma-Aldrich.
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obtained from Novagen as a DE3 Competent Cell Set 1
and contained the following strains: BL21(DE3) (geno-
type: F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3)); BLR
(DE3) (genotype:F- ompT hsdSB(rB- mB-) gal dcm (DE3)
Δ(srl-recA)306::Tn10 (TetR)); HMS174(DE3) (genotype:
F- recA1 hsdR(rK12- mK12+) (DE3) (Rif R)); Turner
(DE3) (genotype: F– ompT hsdSB (rB– mB–) gal dcm lacY1
(DE3)); and NovaBlue(DE3) (genotype: endA1 hsdR17
(rK12– mK12+) supE44 thi-1 recA1 gyrA96 relA1 lac (DE3)
F'[proA+B+ lacI qZDM15::Tn10] (TetR) .Isolation of plasmid DNA from S. cerevisiae
A 1 ml culture of yeast was pelleted and suspended in
0.5 mls of Smash and Grab buffer (20 mM Tris pH 8.0,
5 mM EDTA, 100 mM NaCl, 1% SDS, 2% Triton X-
100). Cells were vortexed with acid glass beads for
1 min. The aqueous phase was isolated after 2 extrac-
tions with 0.3 mls of buffered Phenol:Chloroform:Isoa-
myl alcohol (25:24:1). DNA was precipitated with the
addition of 3 volumes EtOH and allowed to dry. DNA
was resuspended in 50 μL of TE (10 mM Tris pH 8.0,
1 mM EDTA) and incubated at 55°C for 1 hr. DNA
(5 μls) was transformed in the SURE ((Stop Unwanted
Rearrangement Events: e14-(McrA-) Δ(mcrCB-hsdSMR-
mrr)171 endA1 gyrA96 thi-1 supE44 relA1 lac recB recJ
sbcC umuC::Tn5 (Kanr) uvrC [F0 proAB lacIqZΔM15 Tn10
(Tetr)]) cells (Strategene, Agilent, Santa Clara, CA) by elec-
troporation. Sure cells were plated on LB-agar plates con-
taining 100ug/ml ampicilin and grown for 18 hr at 37°C.Construction of the pDEP Plasmids
The yeast centromere vector pRS316 [5] was used as the
basis for the pDEP vectors. A series of PCR products
were produced that contained 50 bp flanking sequences
of homology to the neighboring cassettes, Additional file
1: Figure S1. These homologous flanking regions were
encoded in the PCR oligo primers. The DNA fragments
were: the CUP1 promoter (bp −520 to −33 of S. cerevisiae
CUP1-1 gene); a fragment containing the T7lac promoter
and ribosomal binding site (aaggag); a sequence encoding a
GST fusion protein (Glutathione-S-transferase: Schisto-
soma japonicum ) followed by a TEV (Tobacco Etch virus)
protease cleavage site; and the CYC1 3’ untranslated region
for transcription termination (bp +287 to +205 of CYC1
gene). Vector pRS316 was digested with endonucleases
NotI and KpnI. All DNA fragments were precipitated with
ethanol and transformed into BY4742 yeast. After the ini-
tial pDEP plasmid was isolated from yeast, it was modified
to contain a multiple cloning site from pRS306 (bp 1995–
2099) by recombining a PCR amplicon containing NotI/
SmaI/HindII/SalI/ and XhoI to produce pC-DEPC [10].The CUP1 promoter of the pC-DEPC derivative was
replaced with the methionine-regulated MET25 promoter
to produce the pM-DEPC plasmid. A PCR product encod-
ing bp −1 to −500 of MET25 gene was cotransformed with
the pC-DEPC plasmid digested with SacII and BamHI re-
striction enzymes. Recombinant plasmids were screened
in yeast showing robust expression when grown in the ab-
sence methionine and showing no or modest expression in
presence of 100 μM CuCl2, 200 μg/ml methionine. Both
pC-DEPC and pM-DEPC were fully sequenced. The pC-
DEPN plasmid was made by first digesting pC-DEPC vector
with NotI and NarI. Blunt ends were created with Klenow
fragment and the plasmid was ligated back together. pC-
DEP-ROP was made by creating two amplicons encoding
the S. pome His5 gene driven by the TEF1 promoter and
the ROP fragment. These were recombined into pC-DEPC
to take the place of the URA3 gene and F1 ori.Construction of pC-DEPC containing ubiquitin-like
proteins
Expression plasmids for production of GST-fused to Atg8
(residues 26–117), Esc2 (residues 389–456), Rad23 (resi-
dues 1–77), SUMO (Smt3 residues 1–101), Dsk2 (residues
aa 1–77), and Hub1 (residues 1–74) were produced. PCR
fragments containing the gene of interest were produced
from yeast genomic DNA as template.Screening yeast transformants for expression of
recombinant protein
Single yeast transformants were grown in 2-10 mL of
yeast synthetic complete media SD-Ura-Met, in the pres-
ence of copper chloride if necessary, for 18 hr at 30°C. One
OD600 (~ 0.5 mls) of cells were pelleted and resuspended
in 100μls of volume of 0.2 M NaOH, incubated for 10 min
at room temperature, and then repelleted. The cell pellet
was suspended in 200μL of TWIRL buffer (8 M urea, 5%
SDS, 0.4 M Tris pH 6.8) and heated to 100°C for 5 min.
Samples were then immunoblotted with α-GST antibodies
and positive recombinants were identified on the basis of
an apparent molecular weight greater than GST (26 kDa).Optimized bacterial transformation and protein
expression
For expression in BL21 (DE3) cells, pDEP plasmids were
transformed into chemically competent cells followed by
heat shock at 42°C for 30 sec and then incubated on ice
for 10 min. Cells were then cultured in 20 volumes of
SOC media at 37°C for 30 min and then grown over-
night in 10 mls of LB + 0.25X amp containing 1% glu-
cose. For production of recombinant proteins, bacteria
were then diluted 1:100 in LB + amp media, grown for
2 hrs and induced with 0.2 mM IPTG for 2–4 hrs.
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Additional file 1: Figure S1. Strategy for making the initial pDEP vector.
Schematic of overlapping PCR products that were used in a multi-part
homologous recombination event in yeast to yield the initial pDEP
vector. The 3’ sequence downstream of the GST ORF of this plasmid was
replaced with the multiple cloning site of pRS306 to produce the pC-
DEPC plasmid. Oligonucleotides used to generate the 5 PCR products
that were integrated into linearized pRS316 plasmid.
Additional file 2: Figure S2. Optimization of pDEP plasmid
transformation in bacterial cells. The indicated plasmids were transformed
into chemically competent BL21 (DE3) cells by incubating 200 ng of
plasmid with 15 μls of cells for 20 min on ice followed by 30 min
recovery in SOC media. Cells were then cultured in LB media containing
50 μg/ml or 25 μg/ml ampicillin for 12 hrs. pET151 is a bacterial
expression plasmid. A table showing ampicillin-resistant growth of BL21
(DE3) cells transformed with different plasmids under the indicated
conditions. Note that the lower ampicillin concentration (25 μg/mL) has
the largest effect increasing transformation efficiency of the pDEP
plasmids. Schematic of the pC-DEPC-ROP plasmid. The ROP sequence and
HIS5 gene replace the f1 ori and URA3 gene of the pC-DEPC plasmid. The
incorporation of the ROP sequence limits the plasmid copy number.Competing interests
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